XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (7,814) $ (7,805)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of derivative liability (3,026) (2,051)
Stock-based compensation expense 2,094 1,228
Foreign exchange loss (gain) 244 (71)
Depreciation expense 27 32
Amortization expense 21 109
Fixed asset impairment   159
Provision for (reversal of) inventory reserve 28 2
Non-cash operating lease expense 31 38
Changes in operating assets and liabilities:    
Accounts receivable 89 (23)
Other receivables 20 236
Inventory (345) 66
Prepaid expense and other current assets 390 323
Operating lease liabilities (34) (40)
Accounts payable 214 (130)
Accrued and other current liabilities (571) (431)
Deferred revenue (31) (24)
Net cash used in operating activities (8,663) (8,382)
Cash flows from investing activities:    
Purchase of property and equipment (5) (26)
Net cash used in investing activities (5) (26)
Cash flows from financing activities:    
Proceeds from issuance of common stock 2,961 284
Proceeds from issuance of warrants 4,829  
Proceeds from exercise of warrants 164 207
Share issuance costs (1,000) (36)
Net cash provided by financing activities 6,954 455
Net decrease in cash and cash equivalents (1,714) (7,953)
Cash and cash equivalents at beginning of period 5,182 14,549
Cash and cash equivalents at end of period 3,468 6,596
Non-cash investing and financing transactions:    
Derivative warrant liability reclassified to equity on exercise of warrants 101 628
Deferred offering costs reclassified to equity upon public offering $ 132  
Warrant Proceeds Due From Transfer Agent   $ 435